Bottom line
How has EPIVX performed?
As of Dec 31, 2024, EPIVX returned +40.5% over the past year, +11.8% a year over five years, +10.8% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $28,000. Its five-year return beat 91% of international stock funds we track. Its best quarter was +32.5% and its worst −18.5%.
Updated Dec 31, 2024
EPIVX annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| EPIVX | +47.2% | +5.1% | +9.8% | +0.5% | +7.1% | +18.4% | +16.7% | −14.5% | +15.1% | +18.0% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in EPIVX
$10,000 invested at the start of 2016 would have been worth about $29,300 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +47.2% | $29,311 |
| 2024 | +5.1% | $19,919 |
| 2023 | +9.8% | $18,956 |
| 2022 | +0.5% | $17,264 |
| 2021 | +7.1% | $17,184 |
| 2020 | +18.4% | $16,043 |
| 2019 | +16.7% | $13,553 |
| 2018 | −14.5% | $11,612 |
| 2017 | +15.1% | $13,579 |
| 2016 | +18.0% | $11,799 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| EPIVX | +40.5% | +11.8% | +10.8% | — |
| International Stock median | +25.5% | +6.4% | +7.6% | — |
Source: Prospectus as of Dec 31, 2024; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jul 31, 2026, EPIVX returned +1.12%, −7.19%, +4.63% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.